Aldeyra Therapeutics (ALDX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ALDX Hot Sheet
Join SI Premium – FREE
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Norwegian Cruise Line Holdings (NYSE: NCLH) PT Raised to $20 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
